BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1511442)

  • 1. Absence of p53 gene mutations in primary nasopharyngeal carcinomas.
    Spruck CH; Tsai YC; Huang DP; Yang AS; Rideout WM; Gonzalez-Zulueta M; Choi P; Lo KW; Yu MC; Jones PA
    Cancer Res; 1992 Sep; 52(17):4787-90. PubMed ID: 1511442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutation in human nasopharyngeal carcinomas.
    Lo KW; Mok CH; Huang DP; Liu YX; Choi PH; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1957-63. PubMed ID: 1295443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A hot-spot mutation of p53 gene in nasopharyngeal carcinoma].
    Chen R; Zhu D; Yin W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):401-4. PubMed ID: 8697986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 gene alterations in nasopharyngeal carcinoma.
    Lo KW; Huang DP; Lau KM
    Cancer Res; 1995 May; 55(10):2039-43. PubMed ID: 7743498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas.
    Sun Y; Hildesheim A; Lanier AE; Cao Y; Yao KT; Raab-Traub N; Yang CS
    Oncogene; 1995 Feb; 10(4):785-8. PubMed ID: 7862458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.
    Wright PA; Lemoine NR; Goretzki PE; Wyllie FS; Bond J; Hughes C; Röher HD; Williams ED; Wynford-Thomas D
    Oncogene; 1991 Sep; 6(9):1693-7. PubMed ID: 1923534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
    Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma.
    Claudio PP; Howard CM; Fu Y; Cinti C; Califano L; Micheli P; Mercer EW; Caputi M; Giordano A
    Cancer Res; 2000 Jan; 60(1):8-12. PubMed ID: 10646842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of p53 gene in gynecologic tumors].
    Yaginuma Y; Yamashita T; Duenas JC; Katayama H; Ishikawa M
    Rinsho Byori; 1994 Mar; 42(3):235-41. PubMed ID: 8152158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
    Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP
    Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the p53 gene in human uterine carcinoma cell lines.
    Yaginuma Y; Westphal H
    Cancer Res; 1991 Dec; 51(24):6506-9. PubMed ID: 1660340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH; Bayona W; Koslow M; Newcomb EW
    Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.
    Ruggeri B; Zhang SY; Caamano J; DiRado M; Flynn SD; Klein-Szanto AJ
    Oncogene; 1992 Aug; 7(8):1503-11. PubMed ID: 1630814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Saito S; Itakura M
    Cancer Res; 1992 Sep; 52(18):5061-4. PubMed ID: 1516062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations.
    Sun Y; Hegamyer G; Colburn NH
    Oncogene; 1993 Mar; 8(3):791-5. PubMed ID: 8437863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
    Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
    Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
    Cote RJ; Jhanwar SC; Novick S; Pellicer A
    Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
    Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.